Business Continuity Risk from Large-Scale Natural Disasters and Infectious Diseases
First written in FY2021. 6 of 13 entries say "Materialised", first in FY2022-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2020: 70 of 111 companies on the "Worse" side.
- FY2026RestatedAnnual report
「The Group is developing a crisis management framework and taking measures in preparation for emergencies. However, if a natural disaster such as a typhoon, earthquake or tsunami, or an infectious disease such as novel influenza, occurs on a scale far exceeding expectations and makes it difficult for facilities in the affected area to operate for an extended period, the Group's operating performance may be affected.」
The risk of facility shutdowns and business continuity disruptions caused by large-scale natural disasters or infectious diseases continues to be disclosed. - FY2024RestatedAnnual report
「Although the Group is working to establish a crisis management framework and implement measures in preparation for emergencies, if natural disasters such as typhoons, earthquakes and tsunamis, or outbreaks of infectious diseases such as novel influenza, occur on a scale significantly exceeding expectations, making it difficult for facilities in the affected region to operate for an extended period, the Group's performance could be affected.」
The risk of facility shutdowns and business continuity disruptions caused by large-scale natural disasters or infectious diseases continues to be disclosed. - FY2024-Q3RestatedAnnual report
「During the nine-month period of the fiscal year under review, there were no events that could materially affect investors' decisions, nor were there any material changes to the risks associated with the business described in the annual securities report for the previous fiscal year.」
It states that there have been no material changes regarding business continuity risk from large-scale natural disasters and infectious diseases. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter of the consolidated fiscal year, there were no material changes in matters that could materially affect investors' decisions or in the business and other risks described in the annual securities report for the previous fiscal year.」
It states that there have been no material changes regarding business continuity risk from large-scale natural disasters and infectious diseases. - FY2023MaterialisedAnnual report
「Losses due to COVID-19」
The Company also recognized ¥3 million in losses attributable to COVID-19 for the fiscal year ended March 2023, with costs arising from the infectious disease recorded in full-year results. - FY2023-Q3MaterialisedAnnual report
「Although there were temporary effects from the COVID-19 outbreak in the second and third quarters,」
The temporary impact of COVID-19 on the business was reflected in actual results in the explanation of cumulative performance for the third quarter. - FY2023-Q2MaterialisedAnnual report
「Losses due to COVID-19」
The Company recognized ¥2 million in losses attributable to COVID-19. Costs related to infectious disease risk were reflected in actual results for the second quarter. - FY2023-Q1RestatedAnnual report
「During the first quarter, there were no significant changes to the major risks recognized as potentially having a material impact on the financial position, operating results or cash flows of the consolidated companies, among the matters concerning the business and financial condition described in this quarterly report, or to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
It states that there have been no material changes regarding business continuity risk from large-scale natural disasters and infectious diseases. - FY2022MaterialisedAnnual report
「Losses attributable to COVID-19: ¥47 million」
The Company recognized ¥47 million as losses attributable to COVID-19, including fixed costs of facilities closed in response to requests from the government and local authorities. - FY2022-Q3MaterialisedAnnual report
「Losses attributable to COVID-19: ¥33 million」
The Company recognized ¥33 million as extraordinary losses attributable to COVID-19, including fixed costs of facilities closed in response to requests from the government and local authorities. - FY2022-Q2MaterialisedAnnual report
「Losses attributable to COVID-19: ¥29 million」
The Company recognized ¥29 million as losses attributable to COVID-19, including fixed costs of facilities closed in response to requests from the government and local authorities. Costs related to infectious disease risk have been reflected in actual results. - FY2022-Q1MitigatedAnnual report
「As a measure against COVID-19, the Group continues to provide services with thorough hygiene controls and has implemented measures such as switching to services provided from home when necessary.」
While specific measures, including hygiene controls, switching to services provided from home and online delivery, have been established, the uncertainty regarding the spread of infection and when it will subside continues to be disclosed. - FY2021First statedAnnual report
「If natural disasters such as typhoons, earthquakes and tsunamis, or outbreaks of infectious diseases such as novel influenza and COVID-19, occur on a scale significantly exceeding expectations, making it difficult for employees engaged in platform services and employees responsible for maintaining and managing infrastructure such as information systems to work for an extended period, the Company's performance could be affected.」
While working to establish a crisis management framework, the document identifies the impact on employee and system operations as a risk.